XBiotech Inc

XBiotech Inc(XBIT)の株価予測

$2.220

-0.077 (-3.48%)終値時点

価格予想

1-Day Price Prediction
+0.65%
1-Week Prediction
+3.59%
1-Month Prediction
2026 Prediction
2030 Prediction

アプリで開くと、より長期の予想を確認できます。

Loading chart…

類似チャート分析による XBIT の予測・予想

Alphio's XBIT stock price prediction model matches the current XBiotech Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.20 (+0.65%). The 1-week path is $2.27 (+3.59%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

XBiotech Inc 株は買うべき?

XBiotech Inc. is not a good buy right now due to significant ongoing losses and negative performance trends. The current price is $2.27, with a year-to-date change of -4.62% and a one-year change of -24.83%. The company reported a loss of $6.7 million in Q2 2026, which translates to a per-share loss of $0.22, indicating persistent financial challenges. The RSI is at 38.971, suggesting that the stock is nearing oversold territory but is not yet a buy signal. The main risk is the company's negative earnings trajectory, with a forward P/E of 0 and a price-to-sales ratio of 233.74, indicating overvaluation relative to sales.

XBIT の株価は Tuesday に $2.22 で引け、その前に下落 -3.48%

XBiotech Inc (XBIT) last closed at $2.19, losing -1.35%. These facts feed the 1-day and 1-week XBIT price prediction above.

予想の要因

XBiotech Inc(XBIT)の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

類似チャートパターン

直近の値動きが XBIT に最も近い銘柄を、類似度順に表示します。

XBIT の季節性分析

Historically the probability of a positive September return for XBIT is 46.51%. May offers the highest probability of a positive month at 65.08%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める